universita' degli studi di milano - Alessandro Guerini Rocco

153. Firestein, G.S., The T cell cometh: interplay between adaptive immunity and
cytokine networks in rheumatoid arthritis. J Clin Invest, 2004. 114(4): p. 471-
4.
154. Dijsselbloem, N., W. Vanden Berghe, A. De Naeyer, and G. Haegeman, Soy
isoflavone phyto-pharmaceuticals in interleukin-6 affections. Multi-purpose
nutraceuticals at the crossroad of hormone replacement, anti-cancer and antiinflammatory
therapy. Biochem Pharmacol, 2004. 68(6): p. 1171-85.
155. Kontsek, P., G. Karayianni-Vasconcelos, and E. Kontsekova, The human interferon
system: characterization and classification after discovery of novel
members. Acta Virol, 2003. 47(4): p. 201-15.
156. Sacca, R., C.A. Cuff, and N.H. Ruddle, Mediators of inflammation. Curr Opin
Immunol, 1997. 9(6): p. 851-7.
157. Rot, A. and U.H. von Andrian, Chemokines in innate and adaptive host defense:
basic chemokinese grammar for immune cells. Annu Rev Immunol, 2004.
22: p. 891-928.
158. Lin, H.L. and S. Murphy, Regulation of astrocyte nitric oxide synthase type II
expression by ATP and glutamate involves loss of transcription factor binding
to DNA. J Neurochem, 1997. 69(2): p. 612-6.
159. Muhl, H. and J. Pfeilschifter, Endothelial nitric oxide synthase: a determinant
of TNFalpha production by human monocytes/macrophages. Biochem Biophys
Res Commun, 2003. 310(3): p. 677-80.
160. Greten, F.R. and M. Karin, The IKK/NF-kappaB activation pathway-a target
for prevention and treatment of cancer. Cancer Lett, 2004. 206(2): p. 193-9.
161. Sen, R. and D. Baltimore, Inducibility of kappa immunoglobulin enhancerbinding
protein Nf-kappa B by a posttranslational mechanism. Cell, 1986.
47(6): p. 921-8.
162. Sen, R. and D. Baltimore, Multiple nuclear factors interact with the immunoglobulin
enhancer sequences. Cell, 1986. 46(5): p. 705-16.
163. Ghosh, S., M.J. May, and E. Kopp, NF-κB and Rel proteins: Evolutionarily
conserved mediators of immune responses. Annu Rev Immunol, 1998. 16: p.
225-60.
164. Baeuerle, P.A. and D. Baltimore, I kappa B: a specific inhibitor of the NFkappa
B transcription factor. Science, 1988. 242(4878): p. 540-6.
165. Baeuerle, P.A. and D. Baltimore, Activation of DNA-binding activity in an
apparently cytoplasmic precursor of the NF-kappa B transcription factor.
Cell, 1988. 53(2): p. 211-7.
166. Baeuerle, P.A., M. Lenardo, J.W. Pierce, and D. Baltimore, Phorbol-ester-induced
activation of the NF-kappa B transcription factor involves dissociation
of an apparently cytoplasmic NF-kappa B/inhibitor complex. Cold Spring
Harb Symp Quant Biol, 1988. 53 Pt 2: p. 789-98.
167. Verma, I.M., J.K. Stevenson, E.M. Schwarz, D. Van Antwerp, and S. Miyamoto,
Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.
Genes Dev, 1995. 9(22): p. 2723-35.
168. Grilli, M., J.J. Chiu, and M.J. Lenardo, NF-kappa B and Rel: participants in a
multiform transcriptional regulatory system. Int Rev Cytol, 1993. 143: p. 1-62.
169. Kopp, E.B. and S. Ghosh, NF-kappa B and rel proteins in innate immunity.
Adv Immunol, 1995. 58: p. 1-27.
133